Vanguard National Trust’s Cerence CRNC Stock Holding History

Vanguard National Trust’s Portfolio CRNC Stock Details CRNC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-37	Closed	-$233	–	795
2026 Q1	$233	Buy	+37	New	+$333	﹤0.01%	739

Other funds holding CRNC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return

ACM

American Capital Management New York $2.23B AUM 28.03% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

NSGL

No Street GP LP San Francisco, California $1.66B AUM 39.91% 1-Year Est. Return

OFCM

One Fin Capital Management San Francisco, California $310M AUM 45.19% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Vanguard National Trust's CRNC Position: Q2 2026 in Review

Vanguard National Trust sold out of Cerence (CRNC) in Q2 2026, closing a stake of 37 shares — an estimated $233 sold.

Vanguard National Trust first reported a position in CRNC in Q1 2026 and held it in 1 quarter. The position peaked at $233 in Q1 2026. 193 funds tracked by Wall St. Rank hold CRNC as of Q2 2026.

Vanguard National Trust reported no remaining Cerence position as of Q2 2026 after selling out during the quarter.
Vanguard National Trust sold 37 Cerence shares in Q2 2026, an estimated $233.
Vanguard National Trust first reported a position in Cerence in Q1 2026 and held it in 1 quarter.
Vanguard National Trust's Cerence position peaked at $233 in Q1 2026.
193 funds tracked by Wall St. Rank held Cerence as of Q2 2026.

Based on Vanguard National Trust's 13F filing for Q2 2026, filed 13 Aug 2026.